• 대한핵의학회지
• /
• 제30권1호
• /
• pp.145-151
• /
• 1996

철분이 축적하는데는 Tf나 Tf수용체에 의해 중재되는 경로와 비의존적인 경로가 둘 다 보고되어 왔다. 종양영상에 많이 사용되고 있는 Ga-67은 철분 유사 물질로 이러한 철분의 섭취 경로와 같은 경로에 의해 섭취되는지는 확실하지 않지만 Ga도 Tf의존성과 비의존성 섭취 경로가 보고되었으며 부분적으로는 철분과 같은 섭취경로를 공유할 수도 있다. 또한 종양의 변형정도에 따라 방사성 금속의 섭취기전이 다를 수도 있다. 변형세포로서 MMSV/3T3 세포와 비변형세포로서 BALB/3T3 세포를 Tf이 존재할때와 존재하지 않을 때에서 1uM의 Ga-67-citrate 혹은 Fe-59-chloride 와 함께 $37^{\circ}C$에서 15분간 배양하였다. 그 후 단일층의 세포를 HBSS로 3번, PBS로 1번 씻은 후 1% SDS로 용해시킨 후 감마카운터로 방사능을 측정한 후 단백질양을 측정하여 pmole metal/mg cellular protein으로 표시하였다. Fe-59와 Ga-67의 섭취양상은 71결합형과 이온형 둘다에서 크기의 차이는 있지만 비슷한 양상을 보였다. 즉 두 방사성 금속은 Tf 결합형과 이온형으로 세포로 들어간다. Tf과 함께 존재할 때는 철분이나 Ga 섭취가 변형세포에서 비변형세포에 비해 약 3배 이상 높았으나 Tf이 없이 이온형으로 존재할 때는 이와는 반대로 비변형세포에 의한 섭취가 변형세포에 비해 약4배 더 많았다. Ga-67이나 Fe-59의 섭취의 효율성은 Tf결합형인 Ga-Tf, Fe-Tf 형태가 이온형에 비해 약 10-15배 더 컸다. 그러나 섭취는 효율성의 크기는 Ga-67(3배)에 비해 Fe-59(10배)가 더 컸다. Ga-67의 섭취는 Tf의존성과 Tf비의존성 기전이 같이 존재하며 변형세포와 비변형세포는 서로 반대로 작용하였다. 즉 변형세포의 섭취는 Tf의존성 기전에 의하고, 비변형세포의 섭취는 Tf 비의존성 기전에 의해 주로 일어나며 종양조직에 의한 Ga-67의 섭취 기전은 부분적으로는 Fe-59와 같은 섭취기전을 공유할 수 있다고 생각되었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권14호
• /
• pp.5883-5887
• /
• 2015

Despite recent advances in therapeutic strategies for lung cancer, mortality still is increasing. In the present study, we investigated the anti-cancer effects of KMU-193, 2-(4-Ethoxy-phenyl)-N-{5-[2-fluoro-4-(4-methylpiperazine-1-carbonyl)-phenylamino]-1H-indazol-3-yl}-acetamide in a human non-small cell lung cancer cell line A549. KMU-193 strongly inhibited the proliferation of A549 cells, but it did not have anti-proliferative effect in other types of cancer cell lines. KMU-193 further induced apoptosis in association with activation of caspase-3 and cleavage of PLC-${\gamma}1$. However, KMU-193 had no apoptotic effect in untransformed cells such as TMCK-1 and BEAS-2B. Interestingly, pretreatment with z-VAD-fmk, a pan-caspase inhibitor, strongly abrogated KMU-193-induced apoptosis. KMU-193 treatment enhanced the expression levels of p53 and PUMA. Importantly, p53 siRNA transfection attenuated KMU-193-induced apoptosis. Collectively, these results for the first time demonstrate that KMU-193 has strong apoptotic effects on A549 cells and these are largely mediated through caspase-3- and p53-dependent pathways.

• IMMUNE NETWORK
• /
• 제4권4호
• /
• pp.205-215
• /
• 2004

In the early host defense system, effector function of natural killer (NK) cells results in natural killing against target cells such as microbe-infected, malignant, and certain allogenic cells without prior stimulation. NK cell cytotoxicity is selectively regulated by homeostatic prevalence between a repertoire of both activating and inhibitory receptors, and the discrimination of untransformed cells is achieved by recognition of major histocompatibility complex (MHC) class I alleles through inhibitory signals. Although it is well known that the bipotential T/NK progenitors are derived from the common precusor, functional mechanisms in terms of the development of NK cells remain to be further investigated. NK cells are mainly involved in innate immunity, but recent studies have been reported that they also play a critical role in adaptive immune responses through interaction with dendritic cells (DC). This interaction will provide effector functions and development of NK cells, and elucidation of its precise mechanism may lead to therapeutic strategies for effective treatment of several immune diseases.

• Bulletin of the Korean Chemical Society
• /
• 제25권8호
• /
• pp.1147-1150
• /
• 2004

Hypericin (1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione), an antidepressant which is also known to be a potent protein kinase C (PKC) inhibitor was synthesized as a precursor for radioiodine labeling via two step reactions. Malignant glioma cells express higher PKC activity compared to untransformed glial cell. Here we report the synthesis and radioiodine labeling of hypericin as a potential brain tumor imaging radiopharmaceutical. The reference compound, 2-iodohypericin, and its radiolabelled analogues, 2-[$^{123}I$]iodohypericin and 2-[$^{124}I$]iodohypericin have been prepared by the reaction of hypericin with NaI or [$^{123}I$]NaI or [$^{124}I$]NaI. The labeling yield was 60-65% for each analogue and the optimal reaction time was 10 min. The purification and isolation of the labelled products were achieved by a reversed-phase HPLC.

• Toxicological Research
• /
• 제35권2호
• /
• pp.167-179
• /
• 2019

Ovarian cancer is the fifth main cause of pre-senescent death in women. Although chemotherapy is generally an efficient treatment, its side effects and the occurrence of chemotherapeutic resistance have prompted the need for alternative treatments. In this study, ${\alpha}$-mangostin and apigenin were evaluated as possible anticancer alternatives to the chemotherapeutic drug doxorubicin, used herein as a positive control. The ovarian adenocarcinoma cell line SKOV-3 (ATCC No. HTB77) was used as model ovarian cancer cells, whereas the skin fibroblast line CCD-986Sk (ATCC No. CRL-1947) and lung fibroblast line WI-38 (ATCC No. CCL-75) were used as model untransformed cells. Apigenin and doxorubicin inhibited the growth of SKOV-3 cells in a dose- and time-dependent manner. After 72 hr exposure, doxorubicin was mostly toxic to SKOV-3 cells, whereas apigenin was toxic to SKOV-3 cells but not CCD-986Sk and WI-38 cells. ${\alpha}$-Mangostin was more toxic to SKOV-3 cells than to CCD-986Sk cells. A lower cell density, cell shrinkage, and more unattached (floating round) cells were observed in all treated SKOV-3 cells, but the greatest effects were observed with ${\alpha}$-mangostin. With regard to programmed cell death, apigenin caused early apoptosis within 24 hr, whereas ${\alpha}$-mangostin and doxorubicin caused late apoptosis and necrosis after 72 hr of exposure. Caspase-3 activity was significantly increased in ${\alpha}$-mangostin-treated SKOV-3 cells after 12 hr of exposure, whereas only caspase-9 activity was significantly increased in apigenin-treated SKOV-3 cells at 24 hr. Both ${\alpha}$-mangostin and apigenin arrested the cell cycle at the $G_2/M$ phase, but after 24 and 48 hr, respectively. Significant upregulation of BCL2 (apoptosis-associated gene) and COX2 (inflammation-associated gene) transcripts was observed in apigenin- and ${\alpha}$-mangostin-treated SKOV-3 cells, respectively. ${\alpha}$-Mangostin and apigenin are therefore alternative options for SKOV-3 cell inhibition, with apigenin causing rapid early apoptosis related to the intrinsic apoptotic pathway, and ${\alpha}$-mangostin likely being involved with inflammation.

• Journal of Pharmaceutical Investigation
• /
• 제32권3호
• /
• pp.215-221
• /
• 2002

Cephradine is a first generation cephalosporin and has broad spectrum antibacterial activity against gram-positive and gram-negative microorganisms, through inhibition of bacterial cell wall synthesis. Cephradine is useful for treatment of infections of the urinary and respiratory tract, skin and soft tissues. The purpose of the present study was to evaluate the bioequivalence of two cephradine capsules, Cefradine Yuhan (YuHan Corporation) and Broadcef (Ilsung Pharmaceuticals Co. Ltd.), according to the guidelines of Korea Food and Drug Administration (KFDA). The cephradine release from the two cephradine capsules in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution and water). Twenty normal male volunteers, $23.10{\pm}2.90$ years in age and $67.69{\pm}8.04\;kg$ in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one capsule containing 500 mg as cephradine was orally administered, blood was taken at predetermined time intervals and the concentrations of cephradine in serum were determined using HPLC method with UV detector. The dissolution profiles of two cephradine capsules were very similar at all dissolution media. Besides, the pharmacokinetic parameters such as $AVC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AVC_t\;and\;C_{max}$ and untransformed $T_{max}$. The results showed that the differences in $AVC_t,\;C_{max}\;and\;T_{max}$ between two capsules based on the Cefradine Yuhan were -2.87%, -0.96% and -4.85%, respectively. There were no sequence effects between two capsules in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of 1og(0.8) to log(1.25) $(e.g.,\;log(0.93){\sim}log(1.02)\;and\;log(0.88){\sim}log(1.13)\;for \;AVC_t\;and\;C_{max},\;respectively)$. The 90% confidence interval using untransformed data was within ${\pm}20%$ $(e.g., \;-17.54{\sim}7.78\;for\;T_{max})$. All parameters met the criteria of KFDA guideline for bioequivalence, indicating that Broadcef capsule is bioequivalent to Cefradine Yuhan capsule.

• 미생물학회지
• /
• 제32권4호
• /
• pp.271-279
• /
• 1994

${\alpha}$-Amylase와 glucoamylase를 동시에 안정하게 분비하여 전분을 일단계로 직접 에탄올로 발효시킬수 있는 효모 균주를 개발하기 위하여 glucoamylase를 분비하는 Saccharomyces diastaticus hybrid 균주에 쥐의 침샘 유래의 ${\alpha}$-amylase cDNA 유전자를 plasmid vector를 이용하여 도입하였다. 이 균주로부터 효소생산에 필요한 유전자를 잃어버림이 없이 안정하게 분비할 수 있도록 하기 위하여 $\alpha$-amylase 유전자를 효모의 염색체에 삽입시키기 위한 integrating plasmid vector인 YIpMS$\Delta$R(LEU2)를 제작하였다. 이 vector의 효모형질전환에 있어 원형(circular)상태와 제한 효소 XbaI으로 처리된 직선화된(linearized) 상태의 두가지 형태를 비교한 결과 형질전환 효율에서나 형질전환체내의 $\alpha$-amylase 유전자 보유정도가 모두 직선화된 형태의 경우가 원형상태의 경우보다 높았다. Linearized vecotr를 가진 효모 형질전환체에서의 유전자 발현 안정도는 세포분열을 거듭할수록 episomal vecotr에 의한 효모 형질전환체에서의 발현 안정도보다 우수하게 나타났다. 또한 이 linearized vector를 가진 형질전환체는 $\alpha$-amylase와 glucoamylase를 동시에 분비하여 glucoamylase만 분비하는 원균주보다 2배 이상의 전분분해력을 보였다.

• Journal of Pharmaceutical Investigation
• /
• 제36권6호
• /
• pp.405-411
• /
• 2006

Epinastine is an antiallergic drug effective for bronchial asthma, allergic rhinitis, urticaria and dermatitis. Epinastine is topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from the mast cell. The purpose of the present study was to evaluate the bioequivalence of two epinastine hydrochloride tablets, Alesion Tablet (Boehringer Ingelheim Korea Ltd.) and S-napine tablet 10 mg(Sam Chun Dang Pharm. Co., Ltd), according to the guidelines of the Korea Food and Drug Administration(KFDA). The release of epinastine from the two epinastine formulations in vitro was tested using KP VIII Apparatus II method with various dissolution media(pH 1.2, 4.0, 6.8 buffer solution and water). Twenty six healthy male subjects, $23.35{\pm}1.57$ years in age and $66.29{\pm}10.61kg$ in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After two tablets containing 20 mg as epinastine hydrochloride was orally administered, blood was taken at predetermined time intervals and the concentrations of epinastine in serum were determined using HPLC with UV detector. The dissolution profiles of two formulations were similar at all dissolution media. In addition, the pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t.\;C_{max}$ and untransformed $T_{max}$. The results showed that the differences between two formulations based on the reference drug, Alesion tablet, were 1.50, 1.46 and -13.48% for $AUC_t,\;C_{max}\;and\;T_{max}$, respectively. There were no sequence effects between two formulations in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log 0.8 to log 1.25(e.g., log 0.95$\sim$log 1.12 and log 0.93$\sim$log 1.10 for $AUC_t\;and\;C_{max}$, respectively). Thus, the criteria of the KFDA bioequivalence guideline were satisfied, indicating S-napine tablet 10 mg was bioequivalent to Alesion tablet.